Evidence map›Paper›PMID 17660256›Full record

ArticleProtein science : a publication of the Protein Society2007

Probing the local conformational change of alpha1-antitrypsin.

Je-Hyun Baek, Hana Im, Un-Beom Kang, Ki Moon Seong, Cheolju Lee, Joon Kim, Myeong-Hee Yu

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2007. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Je-Hyun BaekFunctional Proteomics Center, Korea Institute of Science and Technology, Seongbuk-gu, Seoul 136-791, Korea.
Hana Im
Un-Beom Kang
Ki Moon Seong
Cheolju Lee
Joon Kim
Myeong-Hee Yu

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The native form of serpins (serine protease inhibitors) is a metastable conformation, which converts into a more stable form upon complex formation with a target protease. It has been suggested that movement of helix-F (hF) and the following loop connecting to strand 3 of beta-sheet A (thFs3A) is critical for such conformational change. Despite many speculations inferred from analysis of the serpin structure itself, direct experimental evidence for the mobilization of hF/thFs3A during the inhibition process is lacking. To probe the mechanistic role of hF and thFs3A during protease inhibition, a disulfide bond was engineered in alpha(1)-antitrypsin, which would lock the displacement of thFs3A from beta-sheet A. We measured the inhibitory activity of each disulfide-locked mutant and its heat stability against loop-sheet polymerization. Presence of a disulfide between thFs3A and s5A but not between thFs3A and s3A caused loss of the inhibitory activity, suggesting that displacement of hF/thFs3A from strand 5A but not from strand 3A is required during the inhibition process. While showing little influence on the inhibitory activity, the disulfide between thFs3A and s3A retarded loop-sheet polymerization significantly. This successful protein engineering of alpha(1)-antitrypsin is expected to be of value in clinical applications. Based on our current studies, we propose that the reactive-site loop of a serpin glides through between s5A and thFs3A for the full insertion into beta-sheet A while a substantial portion of the interactions between hF and s3A is kept intact.

Indexed as

Protein Conformationalpha 1-AntitrypsinAmino Acid SubstitutionAnilino NaphthalenesulfonatesAnimalsBinding SitesCysteineDisulfidesElectrophoresis, Polyacrylamide GelEnzyme StabilityEscherichia coliFluorescent DyesHot TemperatureHumansKineticsMass Spectrometry5,5'-bis(8-(phenylamino)-1-naphthalenesulfonate)alpha 1-AntitrypsinAnilino NaphthalenesulfonatesCysteineDisulfidesFluorescent DyesPancreatic ElastaseRecombinant ProteinsSerine Proteinase Inhibitors

Identifiers

PMID17660256
PMCPMC2206966

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.